Current guidelines state that aspirin therapy should be continued indefinitely for UA/NSTEMI patients, whether they do or not undergo PCI. Clopidogrel or ticagrelor should also be continued for up 12 months for those who did not undergo an intervention. For those patients who did undergo an interviention, clopidogrel, ticagrelor, or prasugrel should be administered for 12 months. Exact duration is dependent on whether the patient was fitted with a bare mental stent BMS, or a drug-eluting stent DES. Specific indications also exist for patients who cannot tolerate aspirin.
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for patient education
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines nonsteroidal anti-inflammatory drugs
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for nitroglycerin
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for calcium channel blockers
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for inhibitors of the RAS